Literature DB >> 12887367

Successful long-term disease-free survival following multimodal treatments in a patient with a repeatedly recurrent refractory adrenal cortical carcinoma.

Yasuhisa Fujii1, Yukio Kageyama, Satoru Kawakami, Hitoshi Masuda, Chizuru Arisawa, Hideki Akamatsu, Takumi Akashi, Kazunori Kihara.   

Abstract

A 47-year-old male patient underwent surgery for a 10-cm adrenal cortical carcinoma. A large invasive adrenal mass was surgically removed en bloc with the right kidney and the lower lobe of the liver. Two months postoperatively, a 7-cm recurrent mass developed in the right psoas muscle. After a partial response was achieved by irradiation (40 Gy) and high-dose chemotherapy (carboplatin and etoposide) with peripheral blood stem cell transplantation, the patient underwent surgery with a wide excision of the psoas muscle. Twelve months after the initial surgery, an 8-cm rib metastasis developed and the patient again underwent surgery after a combination of irradiation (50 Gy) and chemotherapy (cisplatin and etoposide). The patient has been doing well without any evidence of recurrence for 5 years. Refractory or metastatic adrenal cortical carcinomas have been thought to be lethal, therefore, the present case provides support for multimodal treatments of refractory adrenocortical cancers.

Entities:  

Mesh:

Year:  2003        PMID: 12887367     DOI: 10.1046/j.1442-2042.2003.00651.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  3 in total

1.  Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin.

Authors:  Oluf Dimitri Røe; Per Arne Oppegaard; Mona-Elisabeth Revheim; Aud Svindland
Journal:  BMJ Case Rep       Date:  2014-11-12

2.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

3.  Alpha-fetoprotein (AFP)-producing adrenocortical carcinoma--long survival with various therapeutic strategies including a lung resection: report of a case.

Authors:  Wakako Hamanaka; Satoshi Yoneda; Takayuki Shirakusa; Hiroshi Shirahama; Yukie Tashiro; Akinori Iwasaki; Takeshi Shiraishi; Hirohumi Tsuru
Journal:  Surg Today       Date:  2008-02-29       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.